Point72 Asset Management, L.P. - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 178 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q2 2023$1,590,662
-87.5%
25,121
-89.3%
0.01%
-87.2%
Q1 2023$12,678,085
+23.4%
234,129
+20.6%
0.04%
+11.4%
Q4 2022$10,274,524
-66.3%
194,152
-70.4%
0.04%
-71.3%
Q3 2022$30,514,000
+114.0%
655,800
+18.0%
0.12%
+67.1%
Q3 2020$14,258,000
+240.9%
555,643
-0.8%
0.07%
+180.8%
Q3 2019$4,182,000
+243.3%
559,900
+459.9%
0.03%
+333.3%
Q1 2019$1,218,000
-64.4%
100,000
-66.7%
0.01%
-64.7%
Q4 2018$3,421,000
-75.2%
300,352
-52.7%
0.02%
-70.2%
Q3 2018$13,768,000
+310.4%
634,466
+234.2%
0.06%
+338.5%
Q2 2018$3,355,000
-30.9%
189,857
-17.6%
0.01%
-35.0%
Q1 2018$4,852,000
-25.5%
230,494
-48.8%
0.02%
-28.6%
Q4 2017$6,516,000
+58.4%
450,000
+72.6%
0.03%
+55.6%
Q3 2017$4,114,000
+76.1%
260,700
+70.1%
0.02%
+12.5%
Q3 2016$2,336,000
-64.5%
153,300
-9.5%
0.02%
-64.4%
Q2 2016$6,572,000
+2.5%
169,300
-26.6%
0.04%
-8.2%
Q1 2016$6,411,000
-27.4%
230,600
+40.4%
0.05%
-32.9%
Q4 2015$8,832,000
+807.7%
164,200
+575.7%
0.07%
+812.5%
Q3 2015$973,000
-73.3%
24,300
-78.7%
0.01%
-68.0%
Q2 2015$3,645,000
+69.9%
114,100
+27.0%
0.02%
+66.7%
Q1 2015$2,145,00089,8230.02%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sarissa Capital Management LP 640,000$25,626,0006.33%
Redmile Group, LLC 1,322,592$52,957,0004.01%
SENZAR ASSET MANAGEMENT, LLC 556,224$22,271,209,0003.24%
RA Capital Management 314,349$12,587,0001.81%
WALL STREET ASSOCIATES 205,657$8,235,0001.58%
Parametrica Management Ltd 5,400$216,0001.36%
Rhenman & Partners Asset Management AB 165,000$6,607,0001.05%
EAM Investors, LLC 95,168$3,811,0000.60%
Rock Springs Capital Management LP 180,000$7,207,0000.58%
WASATCH ADVISORS LP 1,085,973$43,482,0000.58%
View complete list of INTRA CELLULAR THERAPIES INC shareholders